Improving CRISPR-Cas9’s Rate of Homology-Directed Repair
Integrated DNA Technologies Suggests Strategies to Boost Efficiency, Avoid Blunt-End Incorporation, and Reduce Toxicity
Advances in Nanotherapeutics: Spotlight on Cerium Dioxide
Recent Advances Using Inorganic Nanomaterials Are Opening New and Exciting Avenues for Therapeutic Intervention
What the Top 10 Biopharma CEOs Are Making
Surging Markets Drive Double- and Triple-Digit Percentage Gains for Compensation
Exosomes from Cancer Cells Could Predict Immunotherapy Responses
Immune-Evasion Mechanism May Help Explain the Differences in Responses to Immunotherapy
For full access to this article login to GEN Select now.
Think Epigenetically, Act Therapeutically
The better we know the genome’s regulatory elements, the better we can design drugs that quell or quicken gene expression, as needed.
- In the words of Nobel Prize winner Albert Szent-Györgyi, “Discovery consists of looking at the same thing as everyone else and thinking something different.” Could discovery as understood by Szent-Györgyi be happening in studies of the human genome? For sure, lots of investigators are looking at the genome. ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.